Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats.

Spiller K, Xi ZX, Peng XQ, Newman AH, Ashby CR Jr, Heidbreder C, Gaál J, Gardner EL.

Psychopharmacology (Berl). 2008 Mar;196(4):533-42. Epub 2007 Nov 6.

2.

Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.

Gilbert JG, Newman AH, Gardner EL, Ashby CR Jr, Heidbreder CA, Pak AC, Peng XQ, Xi ZX.

Synapse. 2005 Jul;57(1):17-28.

3.

YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.

Song R, Yang RF, Wu N, Su RB, Li J, Peng XQ, Li X, Gaál J, Xi ZX, Gardner EL.

Addict Biol. 2012 Mar;17(2):259-73. doi: 10.1111/j.1369-1600.2011.00317.x. Epub 2011 Apr 20.

4.

PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats.

Higley AE, Spiller K, Grundt P, Newman AH, Kiefer SW, Xi ZX, Gardner EL.

J Psychopharmacol. 2011 Feb;25(2):263-73. doi: 10.1177/0269881109358201. Epub 2010 Feb 8.

5.

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Pak AC, Ashby CR Jr, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, Gardner EL.

Int J Neuropsychopharmacol. 2006 Oct;9(5):585-602. Epub 2006 Aug 31.

6.

Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats.

Higley AE, Kiefer SW, Li X, Gaál J, Xi ZX, Gardner EL.

Eur J Pharmacol. 2011 Jun 1;659(2-3):187-92. doi: 10.1016/j.ejphar.2011.02.046. Epub 2011 Apr 3.

7.
8.

Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats.

Ross JT, Corrigall WA, Heidbreder CA, LeSage MG.

Eur J Pharmacol. 2007 Mar 22;559(2-3):173-9. Epub 2007 Jan 19.

PMID:
17303116
9.

The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, Gitajn L, Gardner EL.

Neuropsychopharmacology. 2006 Jul;31(7):1393-405. Epub 2005 Oct 5.

10.

The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity.

Thanos PK, Michaelides M, Ho CW, Wang GJ, Newman AH, Heidbreder CA, Ashby CR Jr, Gardner EL, Volkow ND.

Pharmacol Biochem Behav. 2008 Jun;89(4):499-507. doi: 10.1016/j.pbb.2008.02.003. Epub 2008 Feb 8.

12.

Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.

Song R, Bi GH, Zhang HY, Yang RF, Gardner EL, Li J, Xi ZX.

Neuropharmacology. 2014 Feb;77:398-405. doi: 10.1016/j.neuropharm.2013.10.010. Epub 2013 Oct 28.

13.

The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.

Peng XQ, Ashby CR Jr, Spiller K, Li X, Li J, Thomasson N, Millan MJ, Mocaër E, Muńoz C, Gardner EL, Xi ZX.

Neuropharmacology. 2009 Mar;56(4):752-60. doi: 10.1016/j.neuropharm.2008.12.007.

14.

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.

Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, Middlemiss DN, Stemp G, Gardner EL.

J Neurosci. 2002 Nov 1;22(21):9595-603.

15.

Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.

Spiller K, Xi ZX, Li X, Ashby CR Jr, Callahan PM, Tehim A, Gardner EL.

Neuropharmacology. 2009 Jul;57(1):60-6. doi: 10.1016/j.neuropharm.2009.04.006. Epub 2009 Apr 22.

16.
17.

Role of dopamine D3 receptors in the expression of conditioned fear in rats.

Swain SN, Beuk J, Heidbreder CA, Beninger RJ.

Eur J Pharmacol. 2008 Jan 28;579(1-3):167-76. Epub 2007 Oct 13.

PMID:
17996231
18.

A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.

Sun L, Song R, Chen Y, Yang RF, Wu N, Su RB, Li J.

Acta Pharmacol Sin. 2016 Feb;37(2):157-65. doi: 10.1038/aps.2015.96. Epub 2015 Dec 21.

19.

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats.

Xi ZX, Gilbert J, Campos AC, Kline N, Ashby CR Jr, Hagan JJ, Heidbreder CA, Gardner EL.

Psychopharmacology (Berl). 2004 Oct;176(1):57-65. Epub 2004 Apr 9.

20.

Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Xi ZX, Spiller K, Pak AC, Gilbert J, Dillon C, Li X, Peng XQ, Gardner EL.

Neuropsychopharmacology. 2008 Jun;33(7):1735-45. Epub 2007 Aug 29.

Supplemental Content

Support Center